research BPH: costs and treatment outcomes.
Tamsulosin is a cost-effective treatment for BPH symptoms.
Search
for
Sort by
Research
30-60 / 1000+ results
research Chronic Myeloid Leukemia: Part I—Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United States
Adolescents with severe alopecia incur significantly higher healthcare costs.
research Production cost of autologous platelet rich plasma gel
Making platelet-rich plasma gel is cheap, safe, and easy when done by trained professionals.
research Determining Costs-Returns Profitability In Honey Marketing In Cross River State, Nigeria
Honey marketing in Cross River State, Nigeria, is profitable but faces challenges like high transport costs and poor infrastructure.
research 600 Impact of baricitinib on work productivity and indirect costs in adult patients with atopic dermatitis: A meta-analysis of clinical trials
Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.
research Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction
Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.
research Healthcare Utilization and Costs Among US Adolescents With Alopecia Areata
Alopecia areata in US adolescents leads to significant healthcare costs and usage.
research Out-of-Pocket Costs in Alopecia Areata: A Cross-Sectional Study in German-speaking Countries
People with alopecia areata in German-speaking countries spend a lot on their condition, with hair products and treatments being the most costly.
research (163) Cutting Costs, Not Care: New Models for Affordable Men’s Health Medications
Using Mark Cuban Cost Plus Drug Company can save money on men's health medications compared to Medicare.
research 368 The Unanticipated Costs, Deficits, and Other Unexpected Burdens in a Diagnosis of Alopecia Areata
Alopecia areata requires addressing both emotional and financial challenges for better patient care.
research Hair-raising costs: evaluating botulinum toxin treatment for androgenetic alopecia
Botulinum toxin is not effective or cost-efficient for treating male pattern baldness.
research Patient characteristics associated with all-cause healthcare costs of alopecia areata in the United States
Middle-aged patients, those in the Northeast, with comprehensive insurance, extensive hair loss, or additional health issues, and young or older females face higher alopecia areata medical costs.
research A high price toupee: The costs of baldness in Por los pelos
Baldness is stigmatized as unattractive and is often mocked in media, affecting mostly Caucasian men.
research Influence of Clinical and Sociodemographic Factors on the Management, Costs, and Outcomes of Acute Urinary Retention in the Acute Care Setting
Early intervention for acute urinary retention can reduce costs and improve care.
research Response to Ong et al., "Hair-raising costs: evaluating botulinum toxin treatment for androgenetic alopecia."
Botulinum toxin is not effective for treating male hair loss.
research Can You Really Have Too Much of a Good Thing?: How Benevolent Tax Policies Have Attributed to the Explosion of Health Care Costs and How New Policies Threaten to Do More of the Same
research Comparing the burden of illness in patients with alopecia areata vs atopic dermatitis in the US population from a payer perspective
Alopecia areata and atopic dermatitis have similar healthcare costs, but alopecia areata leads to more outpatient and long-term disability expenses.
research Weakly-Supervised Hair SEM Microscope Image Segmentation Using a Priori Structure Information
The method improves hair image segmentation accuracy while reducing annotation costs.
research The impact of alopecia areata on patients' daily lives: A study using social media in France
Alopecia areata significantly affects patients' lives, causing physical, psychological, social, and financial challenges.
research PSS35 COST COMPARISON OF PATIENTS WITH CHRONIC HAND ECZEMA COVERED BY STATUTORY VS. OCCUPATIONAL HEALTH INSURANCES IN GERMANY
Treating chronic hand eczema costs about the same in statutory and occupational health insurances in Germany, but work-related cases may lead to higher indirect costs due to longer work absences.
research Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.
research Racial Disparities in the Cost of Unplanned Hospitalizations after Breast Reconstruction
Racial minorities face higher costs for unplanned hospital visits after breast reconstruction.
research Health Insurance Coverage Mandates: Colorectal Cancer Screening in the Post-ACA Era
Reducing out-of-pocket costs increased colorectal cancer screenings.
research Budget impact analysis of baricitinib for treatment of alopecia areata: A Saudi hospital perspective
Adding baricitinib will increase costs but offers more treatment options for alopecia areata.
research LB1011 Cost and access changes with TNFa inhibitor biosimilars entering the market
Biosimilars lower costs but don't significantly improve access.
research Establishing the financial burden of alopecia areata and its predictors
Alopecia areata costs individuals about 3% of their income, with women, Asians, those with lower income, and more severe symptoms spending more.
research Cost of prevalent psoriasis
Psoriasis increases annual healthcare costs by $4,044 per patient, with biologic treatments costing significantly more than phototherapy.
research Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA
Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.
research Patterns of insurance coverage for wigs in patients with alopecia areata: a cross-sectional survey
Patients with alopecia areata face high costs for wigs due to poor insurance coverage.
research Ex vivo dermatoscopy of scalp specimens and slides
Ex vivo dermatoscopy may lower lab costs and improve diagnosis speed for hair loss biopsies.